Literature DB >> 7908403

1994 revised guidelines for the performance of CD4+ T-cell determinations in persons with human immunodeficiency virus (HIV) infections. Centers for Disease Control and Prevention.

.   

Abstract

This document contains revised guidelines developed by CDC for laboratories performing lymphocyte immunophenotyping assays in human immunodeficiency virus-infected persons. The recommendations in this document reflect current technology in a field that is rapidly changing. The recommendations address laboratory safety, specimen collection, specimen transport, maintenance of specimen integrity, specimen processing, flow cytometer quality control, sample analyses, data analysis, data storage, data reporting, and quality assurance.

Entities:  

Mesh:

Year:  1994        PMID: 7908403

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN: 1057-5987


  14 in total

1.  A single measurement of CD38CD8 cells in HIV+, long-term surviving injecting drug users distinguishes those who will progress to AIDS from those who will remain stable.

Authors:  K S Froebel; G M Raab; C D'Alessandro; M P Armitage; K M MacKenzie; M Struthers; J M Whitelaw; S Yang
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

2.  The Italian quality control study for evaluation of CD4 cells in centres involved in the treatment of HIV-1 patients. Italian CD4 Quality Control Group.

Authors:  F Pandolfi; C Alario; E Girardi; L Rava; G Ippolito; A Kunkl; F Aiuti
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

Review 3.  Immunophenotyping of bronchoalveolar lavage lymphocytes.

Authors:  R J Harbeck
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

4.  Anti-phospholipid antibodies and CD5+ B cells in HIV infection.

Authors:  T Grünewald; G R Burmester; W Schüler-Maué; F Hiepe; F Buttgereit
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

5.  Changes in the levels of some acute-phase proteins in human immunodeficiency virus-1 infected patients, following interleukin-2 treatment.

Authors:  V H Barbai; E Ujhelyi; J Szlávik; I Vietorisz; L Varga; E Fey; G Füst; D Bánhegyi
Journal:  Clin Exp Immunol       Date:  2010-04-09       Impact factor: 4.330

6.  Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients.

Authors:  Joseph A Kovacs; Richard A Lempicki; Igor A Sidorov; Joseph W Adelsberger; Irini Sereti; William Sachau; Grace Kelly; Julia A Metcalf; Richard T Davey; Judith Falloon; Michael A Polis; Jorge Tavel; Randy Stevens; Laurie Lambert; Douglas A Hosack; Marjorie Bosche; Haleem J Issaq; Stephen D Fox; Susan Leitman; Michael W Baseler; Henry Masur; Michele Di Mascio; Dimiter S Dimitrov; H Clifford Lane
Journal:  J Clin Invest       Date:  2005-07-14       Impact factor: 14.808

7.  Prevalence and Persistence of Varicella Antibodies in Previously Immunized Children and Youth With Perinatal HIV-1 Infection.

Authors:  Murli U Purswani; Brad Karalius; Tzy-Jyun Yao; D Scott Schmid; Sandra K Burchett; George K Siberry; Kunjal Patel; Russell B Van Dyke; Ram Yogev; Robert H Lurie; Ram Yogev; Margaret Ann Sanders; Kathleen Malee; Scott Hunter; William Shearer; Mary Paul; Norma Cooper; Lynnette Harris; Murli Purswani; Mahboobullah Baig; Anna Cintron; Ana Puga; Sandra Navarro; Patricia Garvie; James Blood; Sandra Burchett; Nancy Karthas; Betsy Kammerer; Andrew Wiznia; Marlene Burey; Molly Nozyce; Arry Dieudonne; Linda Bettica; Susan Adubato; Janet Chen; Maria Garcia Bulkley; Latreaca Ivey; Mitzie Grant; Katherine Knapp; Kim Allison; Megan Wilkins; Midnela Acevedo-Flores; Heida Rios; Vivian Olivera; Margarita Silio; Medea Jones; Patricia Sirois; Stephen Spector; Kim Norris; Sharon Nichols; Elizabeth McFarland; Alisa Katai; Jennifer Dunn; Suzanne Paul; Gwendolyn Scott; Patricia Bryan; Elizabeth Willen
Journal:  Clin Infect Dis       Date:  2015-09-18       Impact factor: 9.079

8.  Low relative frequencies of CD26(+) CD4(+) cells in long-term nonprogressing human immunodeficiency virus type 1-infected subjects.

Authors:  C Broström; A Sönnerborg; S Lindbäck; H Gaines
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

Review 9.  CD4 immunophenotyping in HIV infection.

Authors:  David Barnett; Brooke Walker; Alan Landay; Thomas N Denny
Journal:  Nat Rev Microbiol       Date:  2008-11       Impact factor: 60.633

10.  The two-year impact of first generation protease inhibitor based antiretroviral therapy (PI-ART) on health-related quality of life.

Authors:  Lars E Eriksson; Göran A Bratt; Eric Sandström; Gun Nordström
Journal:  Health Qual Life Outcomes       Date:  2005-05-04       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.